Literature DB >> 12552461

Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease.

Gregor Zysk1, Gesina Bethe, Roland Nau, Daniela Koch, Valeska C D H Gräfin Von Bassewitz, Hans-Peter Heinz, Ralf R Reinert.   

Abstract

The immune response to pneumococcal capsular polysaccharides (CPSs) and to the pneumococcal surface proteins cell wall-associated serine proteinase A (PrtA), pneumococcal surface protein A (PspA), and Streptococcus pneumoniae pullulanase A was evaluated in 45 patients with invasive pneumococcal disease compared with healthy adults. In serum from patients with meningitis and pneumonia, CPS antibody levels were low, compared with healthy adults; antibody levels did not differ between groups and did not change between phases. Levels of immunoglobulin G directed against the investigated pneumococcal surface proteins in patients with invasive pneumococcal disease were in the same range as in healthy adults. However, median PrtA and PspA antibody levels tended to increase during early convalescent phase. Low levels of CPS antibody, rather than of antibodies directed against the pneumococcal surface proteins, may predispose to invasive pneumococcal infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12552461     DOI: 10.1086/367701

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone.

Authors:  Suzan P van Mens; Sabine C A Meijvis; Henrik Endeman; Heleen van Velzen-Blad; Douwe H Biesma; Jan C Grutters; Bart J M Vlaminckx; Ger T Rijkers
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

2.  Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential.

Authors:  Simon Athlin; Margit Kaltoft; Hans-Christian Slotved; Björn Herrmann; Hans Holmberg; Helle Bossen Konradsen; Kristoffer Strålin
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

3.  Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.

Authors:  Upali R Goonetilleke; Matthew Scarborough; Stephen A Ward; Stephen B Gordon
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

4.  Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse.

Authors:  E Ling; G Feldman; M Portnoi; R Dagan; K Overweg; F Mulholland; V Chalifa-Caspi; J Wells; Y Mizrachi-Nebenzahl
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children.

Authors:  A Hagerman; K M Posfay-Barbe; S Grillet; M M Ochs; R H Brookes; D Greenberg; N Givon-Lavi; R Dagan; C-A Siegrist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-18       Impact factor: 3.267

6.  Characterization of Pneumococcal Genes Involved in Bloodstream Invasion in a Mouse Model.

Authors:  Layla K Mahdi; Mark B Van der Hoek; Esmaeil Ebrahimie; James C Paton; Abiodun D Ogunniyi
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

7.  PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae.

Authors:  Chen-Fang Hsu; Chen-Hao Hsiao; Shun-Fu Tseng; Jian-Ru Chen; Yu-Jou Liao; Sy-Jou Chen; Chin-Sheng Lin; Huey-Kang Sytwu; Yi-Ping Chuang
Journal:  Respir Res       Date:  2018-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.